跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ezetimibe;atorvastatin
首页
药物
ezetimibe;atorvastatin
ezetimibe;atorvastatin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Solid Pharmaceutical Dosage Form
US 2011028456 A1
申请人: CIPLA LTD
优先权: 2008
CN
US
2 件公开
BILAYER TABLET COMPRISING EZETIMIBE AND ATORVASTATIN
EP 4188338 A1
申请人: KRKA D D NOVO MESTO
优先权: 2020
EP
WO
2 件公开
COMPOSITIONS COMPRISING ATORVASTATIN 4-(NITROOXY) BUTYL ESTER AND A HYPOLIPIDEMIC DRUG
US 2011077232 A1
申请人: NICOX SA
优先权: 2008
US
Dispersible tablets containing cholesterol absorption inhibitor and lipid regulating drug, and application thereof
CN 102451161 A
申请人: LIYAN WANG
优先权: 2010
CN
Composition capable of curing abnormal blood lipid
CN 103127115 A
申请人: BEIJING TIANHENG DRUG RES INST
优先权: 2011
CN
PHARMACEUTICAL COMPOSITION OF ATORVASTATIN AND EZETIMIBE
US 2013216619 A1
申请人: RANBAXY LAB LTD
优先权: 2012
US
Pharmaceutical composition containing ezetimibe and atorvastatin
CN 103340852 A
申请人: BEIJING FUKANGREN BIOPHARMACEUTICAL TECHNOLOGY CO LTD
优先权: 2013
CN
Composition containing ezetimibe and atorvastatin calcium and preparation method of composition
CN 104013617 A
申请人: AVENTIS PHARMA HAINAN CO LTD
优先权: 2014
CN
PHARMACEUTICAL BILAYER TABLET COMPOSITION OF ATORVASTATIN CALCIUM AND EZETIMIBE
EP 3360541 A1
申请人: SANOVEL ILAC SANAYI VE TICARET AS
优先权: 2017
EP
Preparation method of ezetimibe atorvastatin calcium tablets
CN 107875129 A
申请人: BEIJING JIALIN PHARMACEUTICAL CO LTD
优先权: 2017
CN
第 1 / 2 页
上一页
下一页
药物
反馈